Cavalry Regimental Supply

Their work is published this week in the American Journal of Obstetrics and Gynecology.The mice were monitored for up to eight weeks. Both four weeks and eight weeks after treatment, fibroid growths were smaller and weighed less. The researchers note that a rat in the EGCG group was no visible tumor at the end of eight weeks.

The researchers say their study suggests that EGCG could be particularly useful for long-term use in women with low weight for a fibroid stop the progression of the tumor and avoid the development of severe symptoms that require major surgery.

In studies of rodents with fibroids tube cells, cells treated with EGCG increased more slowly and are smaller, 48-72 hours. EGCG also led to cell death of fibroids. which was delivered in drinking water was able to induce a dramatic and sustained fibroid size up to eight weeks after treatment.

The researchers say they are currently recruiting participants for human trials.

The disease disproportionately affects African-American women, who are four times more likely to have fibroids than women of other ethnic groups.

Ayman Al-Hendy, MD, PhD Director of Clinical Research at Meharry, said in a press release that the women who have uterine fibroids may lose time from work, have medical expenses, and may require advanced treatment to become.

An extract can be useful in the treatment of uterine fibroids, a condition that affects 25percent -30percent of American women, new research indicates.